C38.3

Clinical Causes: Genetic mutations that lead to abnormal cell growth Exposure to certain carcinogens such as tobacco smoke or asbestos Previous radiation therapy to the chest area Pre-existing medical conditions such as certain autoimmune diseases Infections that may trigger cellular changes, though rare

Key Symptoms: Persistent cough or hoarseness Chest pain or discomfort Shortness of breath or difficulty breathing Swelling of the face, neck, or upper limbs Unexplained weight loss Fever or night sweats Difficulties swallowing

Diagnosis Path: Diagnosing a malignant mediastinal neoplasm involves multiple tests to determine the presence, size, and extent of the tumor. Typically, the process includes: - Imaging studies, such as chest X-ray, computed tomography (CT) scan, or magnetic resonance imaging (MRI), to visualize the mediastinum and identify abnormal masses. - Biopsy procedures, including needle biopsy or surgical biopsy, to obtain tissue samples for microscopic examination. - Positron emission tomography (PET) scans may be used to assess the metabolic activity of the tumor and check for metastasis. - Additional blood tests or imaging may assist in evaluating overall health and tumor spread.

Treatment Protocols: Treatment options depend on the type, size, location, and stage of the tumor, as well as the patient's overall health. Approaches may include: - Surgery: Removal of the tumor, if operable, often accompanied by procedures to address affected nearby structures. - Radiation therapy: Targeted high-energy rays to kill cancer cells or shrink tumors. - Chemotherapy: Use of drugs to destroy cancer cells systemically. - Targeted therapy: Medications designed to interrupt specific molecular pathways involved in tumor growth. - Palliative care: Managing symptoms and improving quality of life, especially in advanced stages. Treatment plans are typically tailored to each individual through a multidisciplinary team approach involving oncologists, thoracic surgeons, radiologists, and other specialists.